Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial

J Hematol Oncol. 2025 Jun 3;18(1):60. doi: 10.1186/s13045-025-01714-1.
No abstract available

Publication types

  • Published Erratum